Luke Reardon Brings Pharmacy Supply Chain Expertise to Avalere Health
Summary
Luke Reardon has joined Avalere’s Financial Services Practice as principal, bringing with him 15 years of experience that ranges from financial consulting to pharmacy solutions strategies.Luke provides new perspective in specialty pharmacies, mergers and acquisitions, analytics, and more, supporting the practice in its work with public and private equity healthcare investors to identify and evaluate business opportunities and risk.
“Luke’s experience in driving market development, acquisition targets, strategic planning, and consumer outreach for a leading pharmacy benefit manager will significantly strengthen our expertise in the pharmaceutical, pharmacy, and related services that have become increasingly relevant for healthcare investors,” said Rob Carter, Practice Director at Avalere Health. “Luke’s expertise will help our team continue to deliver customized, deep, data-driven analysis to quantify relevant risks, opportunities, and trends that inform financial models and support our differentiated diligence approach.”
About Luke Reardon
Luke applies his breadth and depth of experience to advise on projects across the pharmacy supply chain and adjacent areas. His work focuses on transactions in the specialty pharmacy, cell and gene therapy, and technology-driven services sectors.
“I am excited to be joining Avalere in its important work in helping organizations navigate the ever-changing healthcare sector,” Luke said. “I look forward to bringing my experience and insight from working with various pharmaceutical entities and analyzing forthcoming pharmacy trends to guide investors in making critical decisions.”
Prior to joining Avalere, Luke served as the strategy lead for Humana Specialty Pharmacy, overseeing market development initiatives, managing direct-to-consumer outreach, identifying acquisition targets, and working to commercialize and monetize specialty pharmacy capabilities. He also participated in cross-functional initiatives focused on pharmacy trends and IEC/Car-T therapies.
Before to Humana, Luke was a consultant at Alvarez & Marsal, where he specialized in mergers & acquisitions, and at PricewaterhouseCoopers, where he specialized in transfer pricing.
Luke received his Bachelor of Business Administration and Master of Business Administration degrees with a focus in accounting from the University of Dayton. He is also a certified public accountant.
To receive Avalere updates, connect with us.
Avalere Health is an Inovalon company, a leading provider of cloud-based platforms empowering data-driven healthcare. We believe in the power of data, informing actionable insights, delivering meaningful impact, and driving stronger patient outcomes and business economics.
Webinar Replay | Election 2024: What's at Stake for Healthcare?
In this webinar, Avalere experts and guests discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders.